Janet Woodcock, director of the Center for Drug Evaluation and Research (CDER) at the US Food and Drug Administration (FDA), told senators Thursday that FDA is making significant progress in reducing ...

The European equivalent to the U.S. Federal Drug Administration has just 24 generic options for EpiPen in its backlog. Consumers and lawmakers pushing for cheaper alternatives to the EpiPen, an ...

Off-patent medicines provide people with access to high-quality essential treatment options that can be significantly less expensive than branded on-patent medicines. Off-patent therapies — generics ...

The FDA signed off on a second generic option for the abortion pill mifepristone on Tuesday, hours before most of the federal government shut down and despite Republican opposition to the drug. Evita ...

The Food and Drug Administration has accepted Lannett’s abbreviated new drug application for fluticasone propionate and salmeterol inhalation powder in three strengths — a generic of GlaxoSmithKline's ...

PARSIPPANY, N.J. (AP) -- Generic drugmaker Actavis Inc. said Tuesday it has filed an application with federal regulators to market a generic version of the anti-inflammatory drug Rayos. Rayos is ...

The New Generic Top-Level Domains (gTLD) Program: 2026 Round offers organizations the opportunity to fortify security, enhance brand identity, build community, and gain a competitive edge in an ...

ICANN has started to accept applications for new generic top level domains, which will include words for brands, and non-Latin characters. The organisation said that the move "could trigger a dramatic ...

Now that the Food and Drug Administration plans to fast-track generic drug applications in hopes of spurring competition and lowering medicines costs, a key question should be asked: Can the agency ...